- Home
- CERS vs TCMD Comparison
CERS vs TCMD Comparison
Compare CERS & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- TCMD
- Stock Information
- Founded
- CERS 1991
- TCMD 1995
- Country
- CERS United States
- TCMD United States
- Employees
- CERS N/A
- TCMD N/A
- Industry
- CERS EDP Services
- TCMD Medical/Dental Instruments
- Sector
- CERS Technology
- TCMD Health Care
- Exchange
- CERS Nasdaq
- TCMD Nasdaq
- Market Cap
- CERS 347.3M
- TCMD 314.0M
- IPO Year
- CERS 1997
- TCMD 2016
- Fundamental
- Price
- CERS $1.29
- TCMD $9.54
- Analyst Decision
- CERS Strong Buy
- TCMD Hold
- Analyst Count
- CERS 2
- TCMD 3
- Target Price
- CERS $3.50
- TCMD $16.00
- AVG Volume (30 Days)
- CERS 1.0M
- TCMD 317.5K
- Earning Date
- CERS 05-01-2025
- TCMD 05-05-2025
- Dividend Yield
- CERS N/A
- TCMD N/A
- EPS Growth
- CERS N/A
- TCMD N/A
- EPS
- CERS N/A
- TCMD 0.66
- Revenue
- CERS $185,144,000.00
- TCMD $293,164,000.00
- Revenue This Year
- CERS $25.57
- TCMD $10.68
- Revenue Next Year
- CERS $10.54
- TCMD $8.82
- P/E Ratio
- CERS N/A
- TCMD $14.45
- Revenue Growth
- CERS 13.06
- TCMD 5.96
- 52 Week Low
- CERS $1.12
- TCMD $8.61
- 52 Week High
- CERS $2.54
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- CERS 45.00
- TCMD 20.45
- Support Level
- CERS $1.22
- TCMD $8.61
- Resistance Level
- CERS $1.38
- TCMD $14.22
- Average True Range (ATR)
- CERS 0.07
- TCMD 0.48
- MACD
- CERS 0.00
- TCMD -0.51
- Stochastic Oscillator
- CERS 26.92
- TCMD 15.50
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.